SMART
Researchers from SMART’s AMR IRG, NTU and MIT are working together to develop a rapid serological test and a rapid diagnostic test (RDT), based on protein detection.
The new approach avoids malformations that are common in conventional methods, which produce particles that are ovoid in shape and result in poor flowability during manufacturing of medicines.
Partnerships are key to solving some of the most pressing issues in healthcare, Subaiya says.